(1) S. A. Plotkin, W. A. Orenstein, vaccines, third edition, W. B. Saunders company, 1988
(2) R. E. Delman, M Levine Summary of an International Workshop on Typhoid Fever, Rev. Infect. Dis, 1986; 8 (3): 329-349
(3) E. Caumes, Health & Travel, 1999
(4) G. L. Mandell, J. E. Bennet, R. Dolin, enfermedades infecciosas, principios y práctica, Ed. Panamericana, 1997
(5) M. Lhuillier, Study of comined vaccination against yellow FWVWR and measles in infants from six to nine months, J. Biol stand 17-9-15, 1989
(6) D. Mouchon et al, etude de la vaccination combinée rougeole-fievre jaune chez l’enfant african age de 6 à 10 mois bull socpath 83:537-551, 1990
(7) OMS – Ginebra, Viajes internacionales y salud (vacunación exigida y consejos de higiene:14-15, 1998
(8) R. S. Kof. Clinical Manisfestation and diagnosis of hepatitis a virus infection vaccine, vol 10, Suppl. 1:515-517, 1992
(9) E. Vidor y col. Clinical development of a new inactivated hepatitis A vaccine. Infection 24:447-458, 1996
(10) VHPB hepatitis B prevention programmes in the workplace 1995
(11) Fahey, B. J. et al. Minimizing risks for occupational blood-born infections – JAMA 1990; 264:1189-1190
(12) Mullins, N. Et al. Occupational exposure to HIV, hepatitis B, hepatitis C and tuberculosis – Clinics in pediatric medicine and surgery 1998; 15:363-379
(13) Who VHPB Hepatitis B as an occupational Hazard – European Occupational Health Series Nº8 1994: 1-64
(14) Hepatitis B. Often deadly, nearly always preventable – vaccine a inmunization news 1997 5:10
(15) Pasteur Mérieux, Sérums & Vaccins, monografía del producto Verorab, vacuna antirrábica inactivada.
(16) Pasteur Mérieux, Sérums & Vaccins, introducing the most comprehensive for travellers.
(17) Pasteur Mérieux, Connaught Rhone-Poulenc Group. Campaña "You are going overseas…"
(18) Pasteur Mérieux, Connaught; Meningo A + C; 1:7
